Clexane Administration in Dialysis Treatment

Critical Administration Timing

The daily enoxaparin dose must be administered 6-8 hours after hemodialysis completion to minimize bleeding risk at the vascular access site, as recommended by the American Heart Association 1
The risk of major bleeding is highest at vascular access sites immediately post-hemodialysis if enoxaparin is given too close to the dialysis session, with a reported major bleeding rate of 6.8% in hospitalized hemodialysis patients 1
Sheath removal or access site compression should be performed 4 hours after IV enoxaparin or 6-8 hours after subcutaneous enoxaparin to minimize bleeding risk 1

Dialysis catheters are dual-lumen devices with arterial and venous ports used exclusively for blood flow during dialysis, not for medication administration 2, 3

Dialysis catheter ports are designed for high-volume blood flow (≥350 mL/min) during hemodialysis sessions, not for medication administration 3
The arterial port draws blood from the patient to the dialyzer, while the venous port returns filtered blood to the patient—neither is intended for drug delivery 2
Instilling medications into catheter lumens is reserved for specific antimicrobial or antibiotic "lock" solutions during the interdialytic period, not for systemic anticoagulation 2

For dialysis patients requiring therapeutic anticoagulation, consider switching to unfractionated heparin as the preferred alternative, as it does not accumulate in end-stage renal disease and allows for better control 1
If enoxaparin is used, the American College of Chest Physicians recommends reducing the dose to 1 mg/kg subcutaneously once daily (instead of twice daily) for patients with severe renal failure (CrCl <30 mL/min) 1

Never administer enoxaparin immediately before or during hemodialysis, as this dramatically increases bleeding risk at the access site 1
The 6-8 hour post-dialysis window is critical for hemostasis at the vascular access site before introducing systemic anticoagulation 1